lecanemab

Your Results

• KFF Health News: The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers

  August 03, 2023: The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors most likely to suffer from Read More >

• KFF Health News: Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients

  July 07, 2023: The FDA on Thursday gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see Read More >